Private biotechs in Switzerland raised CHF833 million (US$1.002 billion) in 2024, driving an overall increase in capital investment in the sector to $3 billion, up from $2.4 billion in 2023.

The biopharma job market likely won’t turn around until 2026, according to two industry experts. Both cited a need for more ...

Set against a backdrop of barren biotech investment, Vivo Capital has secured $740m to back preclinical and clinical-stage ...

California investment firm Vivo Capital has secured $740 million in commitments to be aimed at preclinical- and ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

Additionally, IO Biotech’s financial position has been bolstered by up to €57.5 million in debt financing from the European Investment Bank, expected to extend its cash runway into the second quarter ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility ... said the plans bring its total investment in central Ohio to more than $1.4 billion ...

Which was hard for me, because I love the funny stuff too. Hannah Silver is the Art, Culture, Watches & Jewellery Editor of Wallpaper*. Since joining in 2019, she has overseen offbeat design trends ...

On Thursday, PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a Nevada-based biotech firm with a market capitalization of $8.2 million, reported the outcomes of its annual meeting of stockholders. According to ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...

SOLASTA Bio has appointed three senior business and industry experts to support the company’s UK and US growth. Emma Axelson, based in Scotland, has joined as chief of staff and will be responsible ...